학술논문

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic
Document Type
Article
Source
In: Multiple Sclerosis Journal. (Multiple Sclerosis Journal, June 2022, 28(7):1121-1125)
Subject
Language
English
ISSN
14770970
13524585